Adiposogenital dystrophy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adiposogenital dystrophy}} | {{Adiposogenital dystrophy}} | ||
{{CMG}} [[Ogechukwu Hannah Nnabude, MD]] | |||
==Overview== | |||
There is no secondary prevention available for [[adiposogential dystrophy]]. | |||
==Primary Prevention== | |||
There is no secondary prevention available for [[adiposogential dystrophy]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] |
Latest revision as of 06:30, 29 December 2021
Adiposogenital dystrophy Microchapters |
Differentiating Adiposogenital dystrophy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Adiposogenital dystrophy secondary prevention On the Web |
American Roentgen Ray Society Images of Adiposogenital dystrophy secondary prevention |
Risk calculators and risk factors for Adiposogenital dystrophy secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
There is no secondary prevention available for adiposogential dystrophy.
Primary Prevention
There is no secondary prevention available for adiposogential dystrophy.